Collectively, our data indicate that inhibition of AKR1C3 sensitized the resistant HCC cells to sorafenib by inducing LD breakdown and mitochondrial lipotoxicity in the xenograft tumor model of HCC. This evidence concerns the gene AKR1C3 and hepatocellular carcinoma.